Trial Profile
A Phase 1, Open-Label, Dose Escalation Study Evaluating the Safety, Tolerability and Pharmacokinetics of AMG 655 in Subjects with Advanced Tumors.
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 31 Mar 2011
Price :
$35
*
At a glance
- Drugs Conatumumab (Primary)
- Indications Hodgkin's disease; Non-Hodgkin's lymphoma; Solid tumours
- Focus Adverse reactions; Pharmacokinetics
- 31 Jul 2006 New trial record.